Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hannah Culpepper
Observed name:
H. Culpepper
Institution:
Medical University of South Carolina
Observed institution:
Medical University of South Carolina
ORCID:
0009-0007-7417-8599
Observed ORCID:
0009-0007-7417-8599
OpenAlex ID:
A5094045613
Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT Study): Protocol for a Randomized Controlled Trial
2024
·
Morgan Overstreet
, Hannah Culpepper
, et al.
·
JMIR Research Protocols
·
3
A Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for Cytomegalovirus (CMV) Prophylaxis in High-Risk Kidney Transplant Recipients: Study Protocol
2025
·
Hannah Culpepper
, Morgan Overstreet
, et al.
·
Cureus
·
1
PDF
Results of a Randomized Controlled Trial Evaluating the Impact of Conversion to LCP Tacrolimus on Neurologic Toxicities in Liver Transplant Recipients
2025
·
Kelsey S. Coffman
, Gonzalo J. Revuelta
, et al.
·
International Journal of Hepatology
·
1
PDF
Single-center, open-label, randomized controlled trial comparing the tolerability of maribavir 400 mg twice daily versus standard-dose valganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients
2026
·
David J. Taber
, Hannah Culpepper
, et al.
·
American Journal of Transplantation
6-Month Outcomes of a Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients
2025
·
H. Culpepper
, N. Patel
, et al.
·
American Journal of Transplantation
PDF
Show more works
View as search
Works count:
5
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type